Literature DB >> 17216281

Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women.

D Gordin1, V Hiilesmaa, J Fagerudd, M Rönnback, C Forsblom, R Kaaja, K Teramo, P-H Groop.   

Abstract

AIMS/HYPOTHESIS: Our aim was to study whether pre-eclampsia and pregnancy-induced hypertension are predictors of diabetic nephropathy in type 1 diabetic women.
MATERIALS AND METHODS: A total of 203 type 1 diabetic women, who were pregnant between 1988 and 1996 and followed at the Department of Obstetrics and Gynaecology in Helsinki, were re-assessed after an average of 11 years within the nationwide, multi-centre Finnish Diabetic Nephropathy Study. Diabetic nephropathy was defined as microalbuminuria, macroalbuminuria or end-stage renal disease.
RESULTS: Patients with prior pre-eclampsia had diabetic nephropathy more often than patients with a normotensive pregnancy (diabetic nephropathy vs normal albumin excretion rate: 41.9% vs 8.9%; p<0.001), whereas patients with a history of pregnancy-induced hypertension did not (10.3% vs 8.9%; p=0.81). CHD was more prevalent in patients with a history of pre-eclampsia than in patients with a normotensive pregnancy (12.2% vs. 2.2%; p=0.03). Pre-eclampsia (odds ratio [OR] 7.7, 95% CI 1.6-36.1; p=0.01) and HbA(1c) (OR 2.0, 95% CI 1.1-3.8; p<0.05) were associated with incident diabetic nephropathy even when adjusted for follow-up time, BMI, smoking, diabetes duration and age. CONCLUSIONS/
INTERPRETATION: These data suggest that a history of pre-eclamptic pregnancy but not pregnancy-induced hypertension is associated with an elevated risk of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216281     DOI: 10.1007/s00125-006-0544-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population.

Authors:  R Arngrimsson; S Björnsson; R T Geirsson; H Björnsson; J J Walker; G Snaedal
Journal:  Br J Obstet Gynaecol       Date:  1990-09

2.  Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.

Authors:  M Saraheimo; C Forsblom; T K Hansen; A-M Teppo; J Fagerudd; K Pettersson-Fernholm; S Thiel; L Tarnow; P Ebeling; A Flyvbjerg; P-H Groop
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

Review 3.  Endothelial dysfunction and pathogenesis of diabetic angiopathy.

Authors:  C D Stehouwer; J Lambert; A J Donker; V W van Hinsbergh
Journal:  Cardiovasc Res       Date:  1997-04       Impact factor: 10.787

4.  A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes.

Authors:  L J Scott; J H Warram; L S Hanna; L M Laffel; L Ryan; A S Krolewski
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

5.  Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency.

Authors:  L P Purdy; C E Hantsch; M E Molitch; B E Metzger; R L Phelps; S L Dooley; S H Hou
Journal:  Diabetes Care       Date:  1996-10       Impact factor: 19.112

Review 6.  Manifestations of chronic disease during pregnancy.

Authors:  Risto J Kaaja; Ian A Greer
Journal:  JAMA       Date:  2005-12-07       Impact factor: 56.272

7.  Pregnancy outcome in type 1 diabetic women with microalbuminuria.

Authors:  P Ekbom; P Damm; B Feldt-Rasmussen; U Feldt-Rasmussen; J Mølvig; E R Mathiesen
Journal:  Diabetes Care       Date:  2001-10       Impact factor: 19.112

Review 8.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

9.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

10.  Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.

Authors:  A R Andersen; J S Christiansen; J K Andersen; S Kreiner; T Deckert
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

View more
  8 in total

Review 1.  Preeclampsia and diabetes.

Authors:  Tracey L Weissgerber; Lanay M Mudd
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

Review 2.  Pre-eclampsia and long-term maternal health.

Authors:  David Williams
Journal:  Obstet Med       Date:  2012-08-20

3.  Pre-Eclampsia Biomarkers for Women With Type 1 Diabetes Mellitus: A Comprehensive Review of Recent Literature.

Authors:  Katrina Z Freimane; Lauren Kerrigan; Kelly-Ann Eastwood; Chris J Watson
Journal:  Front Bioeng Biotechnol       Date:  2022-05-26

Review 4.  Hypertensive pregnancy disorders and future renal disease.

Authors:  Steven Wagner; Iasmina Craici
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

5.  Preeclampsia and prevalence of microalbuminuria 10 years later.

Authors:  Miriam Kristine Sandvik; Stein Hallan; Einar Svarstad; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

6.  Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial.

Authors:  Valerie A Holmes; Ian S Young; Christopher C Patterson; Donald W M Pearson; James D Walker; Michael J A Maresh; David R McCance
Journal:  Diabetes Care       Date:  2011-06-02       Impact factor: 19.112

7.  Long term effects of gestational hypertension and pre-eclampsia on kidney function: Record linkage study.

Authors:  D Ayansina; C Black; S J Hall; A Marks; C Millar; G J Prescott; K Wilde; S Bhattacharya
Journal:  Pregnancy Hypertens       Date:  2016-08-09       Impact factor: 2.899

8.  Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Markku Saraheimo; Milla Rosengård-Bärlund; Outi Heikkilä; Kustaa Hietala; Ken Ong; Nicholas Wareham; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.